Sign up link: https://docs.google.com/forms/d/e/1FAIpQLSeyZ5u2uv1MNg0u1SiE8ux-qCJyFevhQQNIslFqurpX36xqlw/viewform?usp=header
Lunch starts at 11:30am, 11h Floor, KT 1105A
Speaker bio: Mihaela Aslan, PhD, is a graduate from the Department of Statistics at Yale University. As a mathematical statistician, she conducts methodological research from both a Bayesian and frequentist approach on a range of topics on high-dimensional data, such as growth mixture models, network analyses, competing risks in survival analysis, and causal inference methods leveraging electronic medical records to emulate randomized clinical trials, especially when these are impractical. Multi-site observational study design represents another major methodological focus of Dr. Aslan’s research. Some of her representative studies have focused on clinical topics such as prostate cancer, post-traumatic stress disorder (PTSD), neurocognitive health, suicidal ideation and behavior, neurocognition, functional outcomes, aging and their relationships in patients with severe mental illness, Gulf War Illness (GWI), military exposures, major depressive disorder, cardiovascular disease, prediabetes and diabetes, HIV and COVID-19 pharmacotherapies, and most recently, influenza, respiratory syncytial virus (RSV), and acute respiratory distress syndrome (ARDS). In her 24-year tenure with the Yale University School of Medicine and the VA Cooperative Studies Program (CSP), and in her current role as the Director of Clinical Epidemiology Research Center (CERC), her goals are centered around advancing scientific knowledge, helping train the next generation of analysts on applied clinical epidemiology methods, improving translation and implementation of research findings into routine clinical practice to improve patient care and outcomes benefitting real-world populations everywhere, and ultimately building a true learning healthcare system model.